| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |